By-health Co., Ltd. (300146.SZ)
CNY 11.31
(0.09%)
CNY 11.31
(0.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.41 Billion CNY | 16.05% |
| 2022 | 3.77 Billion CNY | 23.37% |
| 2021 | 3.05 Billion CNY | 24.53% |
| 2020 | 2.45 Billion CNY | 11.18% |
| 2019 | 2.2 Billion CNY | 25.82% |
| 2018 | 1.75 Billion CNY | 36.24% |
| 2017 | 1.28 Billion CNY | 45.55% |
| 2016 | 884.76 Million CNY | 5.42% |
| 2015 | 839.28 Million CNY | 45.23% |
| 2014 | 577.89 Million CNY | 21.97% |
| 2013 | 473.8 Million CNY | 29.11% |
| 2012 | 366.98 Million CNY | 53.18% |
| 2011 | 239.57 Million CNY | 105.19% |
| 2010 | 116.75 Million CNY | 71.45% |
| 2009 | 68.1 Million CNY | 38.65% |
| 2008 | 49.11 Million CNY | 159.07% |
| 2007 | 18.95 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 810.38 Million CNY | -30.19% |
| 2024 Q1 | 998.48 Million CNY | -21.29% |
| 2024 Q2 | 1.13 Billion CNY | 13.18% |
| 2023 Q3 | 1.1 Billion CNY | -10.61% |
| 2023 Q1 | 919.34 Million CNY | -23.54% |
| 2023 Q2 | 1.23 Billion CNY | 34.63% |
| 2023 FY | 4.37 Billion CNY | 16.05% |
| 2023 Q4 | 1.26 Billion CNY | 14.67% |
| 2022 Q3 | 910.77 Million CNY | -0.45% |
| 2022 Q2 | 914.89 Million CNY | 23.2% |
| 2022 Q1 | 742.58 Million CNY | -24.57% |
| 2022 FY | 3.77 Billion CNY | 23.37% |
| 2022 Q4 | 1.2 Billion CNY | 32.03% |
| 2021 Q2 | 726.24 Million CNY | 45.36% |
| 2021 Q1 | 499.62 Million CNY | -51.71% |
| 2021 FY | 3.05 Billion CNY | 24.53% |
| 2021 Q4 | 984.43 Million CNY | 16.33% |
| 2021 Q3 | 846.23 Million CNY | 16.52% |
| 2020 Q1 | 303.67 Million CNY | -48.01% |
| 2020 Q4 | 1.03 Billion CNY | 69.27% |
| 2020 Q3 | 611.21 Million CNY | 21.3% |
| 2020 FY | 2.45 Billion CNY | 11.18% |
| 2020 Q2 | 503.87 Million CNY | 65.93% |
| 2019 Q1 | 417.73 Million CNY | -36.78% |
| 2019 Q3 | 613.15 Million CNY | 5.23% |
| 2019 FY | 2.2 Billion CNY | 25.82% |
| 2019 Q4 | 584.07 Million CNY | -4.74% |
| 2019 Q2 | 582.69 Million CNY | 39.49% |
| 2018 FY | 1.75 Billion CNY | 36.24% |
| 2018 Q2 | 404.23 Million CNY | 76.09% |
| 2018 Q1 | 229.55 Million CNY | -57.82% |
| 2018 Q3 | 439.66 Million CNY | 8.76% |
| 2018 Q4 | 660.76 Million CNY | 50.29% |
| 2017 Q3 | 309.6 Million CNY | 19.23% |
| 2017 Q4 | 544.18 Million CNY | 75.76% |
| 2017 FY | 1.28 Billion CNY | 45.55% |
| 2017 Q1 | 164.15 Million CNY | -29.01% |
| 2017 Q2 | 259.67 Million CNY | 58.19% |
| 2016 Q3 | 224.45 Million CNY | 1.33% |
| 2016 Q4 | 231.21 Million CNY | 3.01% |
| 2016 FY | 884.76 Million CNY | 5.42% |
| 2016 Q1 | 190.91 Million CNY | -30.73% |
| 2016 Q2 | 221.51 Million CNY | 16.03% |
| 2015 Q3 | 226.26 Million CNY | 32.6% |
| 2015 FY | 839.28 Million CNY | 45.23% |
| 2015 Q4 | 275.6 Million CNY | 21.8% |
| 2015 Q2 | 170.63 Million CNY | 7.99% |
| 2015 Q1 | 158.01 Million CNY | -13.12% |
| 2014 Q4 | 181.86 Million CNY | 20.53% |
| 2014 Q2 | 125.09 Million CNY | 10.57% |
| 2014 Q3 | 150.88 Million CNY | 20.62% |
| 2014 FY | 577.89 Million CNY | 21.97% |
| 2014 Q1 | 113.14 Million CNY | -6.85% |
| 2013 Q3 | 126.95 Million CNY | 2.17% |
| 2013 FY | 473.8 Million CNY | 29.11% |
| 2013 Q1 | 101.14 Million CNY | -12.91% |
| 2013 Q2 | 124.24 Million CNY | 22.84% |
| 2013 Q4 | 121.45 Million CNY | -4.33% |
| 2012 Q4 | 116.13 Million CNY | 5.36% |
| 2012 FY | 366.98 Million CNY | 53.18% |
| 2012 Q3 | 110.22 Million CNY | 42.27% |
| 2012 Q2 | 77.47 Million CNY | 22.71% |
| 2012 Q1 | 63.13 Million CNY | -25.58% |
| 2011 Q3 | 65.43 Million CNY | 34.47% |
| 2011 Q4 | 84.84 Million CNY | 29.66% |
| 2011 Q1 | 40.64 Million CNY | -2.76% |
| 2011 Q2 | 48.65 Million CNY | 19.7% |
| 2011 FY | 239.57 Million CNY | 105.19% |
| 2010 Q4 | 41.8 Million CNY | 9.53% |
| 2010 Q3 | 38.16 Million CNY | 74.96% |
| 2010 FY | 116.75 Million CNY | 71.45% |
| 2010 Q2 | 21.81 Million CNY | 45.63% |
| 2010 Q1 | 14.97 Million CNY | -44.07% |
| 2009 FY | 68.1 Million CNY | 38.65% |
| 2009 Q3 | 18.44 Million CNY | 0.0% |
| 2009 Q4 | 26.78 Million CNY | 45.18% |
| 2008 FY | 49.11 Million CNY | 159.07% |
| 2007 FY | 18.95 Million CNY | 0.0% |